MedStar Heart & Vascular Institute First to Implant Device in Clinical Trial | MedStar Health
MedStar Heart and Vascular Institute First to Implant Device in Clinical Trial
Friday, January 12, 2018
The clinical trial is investigating a potentially life-changing device proven to reduce the risk of stroke in certain patients with atrial fibrillation. The device, called the WATCHMAN FLX™, is being investigated for greater flexibility and safety while positioning the device in the left atrial appendage. Read more.
Media Contact
Eva Hochberger
Marketing & Communications Manager
301-560-2917Eva.B.Hochberger@medstar.net
Browse by Category
- View all categories
- Ambulatory
- Awards and Accreditation
- Cancer
- Cardiology
- Community Health
- Compliance
- COVID-19
- Diabetes
- Education
- Emergency
- Focus Blog
- Geriatrics
- Hand
- Healthcare Industry
- Healthcare Quality Improvement
- Innovation
- Medical Education
- MedStar Health in the Community
- MedStar Health System News
- MedStar Institute for Innovation
- MedStar Institute for Quality and Safety
- Neurosciences
- Nursing
- Orthopaedics and Sports Medicine
- Pediatrics
- Philanthropy
- Physical Therapy
- Primary Care
- Pulmonology
- Quality and Patient Safety
- Radiology
- Rehabilitation
- Research
- Transplant
- Urgent Care
- Urology
- Wellbeing
- Women’s services